Baxter International Inc said it agreed to buy privately held Swedish dialysis product company Gambro AB for about $4 billion to boost its renal therapies portfolio.

The deal, which is expected to close in the first half of 2013, will be financed through a combination of cash generated from overseas operations and debt.

(Reporting by Esha Dey in Bangalore; Editing by Joyjeet Das)